Abstract:A series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones were synthesized and their anti-HIV-1 activities were evaluated. Most of these compounds were highly active against wild-type (WT) HIV-1 strain (IIIB) with EC50 values in the range of 0.0038-0.4759 mmol/L. Among those compounds, I-11 had an EC50 value of 3.8 nmol/L and SI (selectivity index) of up to 25,468 indicating excellent activity against WT HIV-1. In vitro anti-HIV-1 activity and resistance profile studies suggested that compounds I-11 and I-12 displayed potential anti-HIV-1 activity against laboratory adapted strains and primary isolated strains including different subtypes and tropism strains (EC(50)s range from 4.3 to 63.6 nmol/L and 18.9-219.3 nmol/L, respectively). On the other hand, it was observed that those two compounds were less effective with EC50 values of 2.77 and 4.87 mmol/L for HIV-1A(17) (K103N + Y181C). The activity against reverse transcriptase (RT) was also evaluated for those compounds. Both I-11 and I-12 obtained sub-micromolar IC50 values showing their potential in RT inhibition. The pharmacokinetics examination in rats indicated that compound I-11 has acceptable pharmacokinetic properties and bioavailability. Preliminary structure-activity relationships and molecular modeling studies were also discussed. (C) 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

Anti-Aids Agents 84. Synthesis and Anti-Human Immunodeficiency Virus (hiv) Activity of 2 '-Monomethyl-4-methyl- and 1 '-Thia-4-methyl-(3 ' R,4 ' R)-3 ',4 '-Di-o-(s)-camphanoyl-(+)-cis-khellactone (dck) Analogs

Anti-AIDS Agents. Part 62: Anti-HIV Activity of 2′-Substituted 4-Methyl-3′,4′-di-o-(−)-camphanoyl-(+)-cis-khellactone (4-Methyl DCK) Analogs

Anti-AIDS Agents 87. New Bio-Isosteric Dicamphanoyl-Dihydropyranochromone (DCP) and Dicamphanoyl-Khellactone (DCK) Analogues with Potent Anti-Hiv Activity

Anti-AIDS agents. Part 56: Synthesis and anti-HIV activity of 7-thia-di-O-(−)-camphanoyl-(+)-cis-khellactone (7-thia-DCK) analogs

Anti-AIDS Agents 82: Synthesis of Seco-(3′R,4′r)-3′,4′-di-o-(s)-camphanoyl-(+)-cis-khellactone (DCK) Derivatives As Novel Anti-Hiv Agents

Anti-Aids Agents 72. Bioisosteres (7-Carbon-dcks) of the Potent Anti-Hiv Lead Dck

Synthesis and Anti-Hiv Activity of Trisubstituted (3 ' R, 4 ' R)-3 ',4 '-Di-o-(s)-camphanoyl-(+)-cis-khellactone (dck) Analogs

Anti-AIDS Agents 86. Synthesis and Anti-Hiv Evaluation of 2′,3′-Seco-3′-nor DCP and DCK Analogues

Synthesis and Anti-Hiv-1 Activity of S-Dihydro(Alkyloxy)Benzyloxypyrimidine Derivatives

Synthesis and Biological Evaluation of Novel Hydroxylphenethyl-S-DACOs As High Active Anti-HIV Agents

Computational Studies and Drug Design for HIV-1 Reverse Transcriptase Inhibitors of 3′, 4′-Di-o-(s)-camphanoyl-(+)-cis-khellactone (DCK) Analogs.

Development and Preclinical Studies of Broad-Spectrum Anti-Hiv Agent (3'R,4'r)-3-cyanomethyl-4-methyl-3',4'-di-o-(s)-camphanoyl-(+)-cis-khellactone (3-Cyanomethyl-4-methyl-dck).

Synthesis and Anti-HIV-1 Activity Evaluation of 5-Alkyl-2-alkylthio-6-(arylcarbonyl or Α-Cyanoarylmethyl)-3,4-dihydropyrimidin-4(3h)-ones As Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Synthesis and Biological Evaluation of New Conformationally Restricted S-DABO Hybrids As Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase

Synthesis and anti-HIV activity evaluation of novel 2-(substituted phenylamino-carbonylmethylthio)-DACO analogues

The Anti-Hiv Activity of Three 2-Alkylsulfanyl-6-benzyl-3, 4-Dihydropyrimidin-4 (3H)-One Derivatives Acting As Non-Nucleoside Reverse Transcriptase Inhibitor in Vitro.

Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes As C2-Symmetric HIV-1 Protease Inhibitors and Docking Study.

Prodrug Design, Synthesis and Pharmacokinetic Evaluation of (3′R, 4′R)-3-hydroxymethyl-4-methyl-3′, 4′-Di-o-(s)-camphanoyl-(+)-cis-khellactone

Synthesis and Anti-Hiv Activity of Aryl-2-[(4-Cyanophenyl)Amino]-4-Pyrimidinone Hydrazones As Potent Non-Nucleoside Reverse Transcriptase Inhibitors

Synthesis and Biological Evaluation of a Series of 2-(((5-akly/aryl-1h-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3h)-ones As Potential HIV-1 Inhibitors.

Synthesis and Biological Evaluation of 6‐substituted 5‐alkyl‐2‐(phenylaminocarbonylmethylthio)pyrimidin‐4(3h)‐ones As Potent HIV‐1 NNRTIs